Showing results (901-910 of 9,109) with videos related to
Sort By:
Pageof 911
Cancer Medicine|January 10, 2018
Can therapeutic drug monitoring increase the safety of Imatinib in GIST patients?Wei Zhuang, Jing-Dun Xie, Shan Zhou, et al.Cancer Medicine|January 11, 2018
The synergistic role of ATP-dependent drug efflux pump and focal adhesion signaling pathways in vinorelbine resistance in lung cancerTakao Nakanishi, Toshi Menju, Shigeto Nishikawa, et al.Cancer Medicine|May 16, 2022
A practical framework RNMF for exploring the association between mutational signatures and genes using gene cumulative contribution abundanceZhenzhang Li, Haihua Liang, Shaoan Zhang, et al.Cancer Medicine|May 19, 2022
Integration of bioinformatics analysis and experimental validation identifies plasma exosomal miR-103b/877-5p/29c-5p as diagnostic biomarkers for early lung adenocarcinomaJing Wu, Zian Feng, Rui Wang, et al.Cancer Medicine|May 19, 2022
The effect of exercise training on endothelial function in postmenopausal women with breast cancer under aromatase inhibitor therapyBarbara Mayr, Bernhard Reich, Richard Greil, et al.Cancer Medicine|May 19, 2022
Minimal residual disease assessment of papillary thyroid carcinoma through circulating tumor cell-based cytologyNadia Innaro, Rita Gervasi, Teresa Ferrazzo, et al.Cancer Medicine|May 19, 2022
Exosomes and their roles in the chemoresistance of pancreatic cancerYubin Pan, Honglin Tang, Qijun Li, et al.Cancer Medicine|May 19, 2022
Dose of intra-operative opioids has no impact on recurrence or survival in primary liver cancerLiuyuan Zhao, Lei Teng, Wenhui Zhang, et al.Cancer Medicine|May 13, 2022
A necroptosis-related gene signature for predicting prognosis, immune landscape, and drug sensitivity in hepatocellular carcinomaJunliang Chen, Huaitao Wang, Lei Zhou, et al.Cancer Medicine|May 15, 2022
Changes in the cervicovaginal microbiota composition of HPV16-infected patients after clinical treatmentChao Li, Zhenbo Zhang, Yixia Yang, et al.Pageof 911